Working towards a COVID-19 vaccine, Selvaraj and Kaliamurthi use artificial intelligence and reverse vaccinology.

In many remote locations, access to medical supplies, which can make the difference between a speedy recovery and death, can be limited because of their sensitivity to temperature variations during transport.

One company that’s addressing the need for a vaccine is Medicago, a biopharmaceutical company that’s using a new manufacturing technology based on Plants and Virus-like Particles (VLP). Medicago is creating a vaccine that has the potential to promote antibody production, and unlike cell culture systems, plant systems do not require complicated growth or storage conditions.

Research abroad results in development of special virus-killing coating for masks

‘Buddy’ is no friend to maple syrup producers, costing the industry millions of dollars each year across eastern North America.

Researchers outfit Alberta start-up with help needed to launch first-of-its-kind workwear for women in trades.

On the heels of news that global carbon dioxide (CO2) emissions are soaring to record-breaking levels not seen in 800,000 years, Calgary-based SeeO2 Energy is working to reverse the trend.

For Professor Martin Ordonez’s team at the UBC Department of Electrical & Computer Engineering who work in power electronics and conversion, one of the ways of being ahead is developing clean energy through research in renewable electric vehicles (EV) and power storage.

Canada’s law enforcement agencies can soon be on the lookout for ‘lone wolf’ terrorists at public events using an unexpectedly useful tool: computers.

Celebrating 1,500 interns in 2018 and 20 years together— UBC-Mitacs partnership continues to drive innovation and improve lives

Mitacs supports USask team developing unique harness to help save injured horses